Prevalence of toscana and sicilian phlebovirus antibodies in classic Kaposi sarcoma case patients and control subjects in sicily

Journal of Infectious Diseases

Volumn 204, Issue 9, 2011, Pages 1423-1426

  Amodio, Emanuele ^a   Valentini, Melissa ^b   Gori Savellini, Gianni ^b   Valenti, Rosalia Maria ^a   Romano, Nino ^a   Goedert, James J ^c   Cusi, Maria Grazia ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; SICILIAN PHLEBOVIRUS ANTIBODY; TOSCANA PHLEBOVIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTHROPOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ITALY; KAPOSI SARCOMA; MALE; NONHUMAN; PHLEBOVIRUS; PHLEBOVIRUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; SICILIAN PHLEBOVIRUS; TOSCANA PHLEBOVIRUS;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; COMORBIDITY; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITALY; MALE; MIDDLE AGED; PHLEBOVIRUS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

EID: 80053430443     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir546     Document Type: Article

References (17)

1. Mbulaiteye S, Marshall V, Bagni RK, et al. Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 2006; 193:1250-7.
2. Vamvakas EC. Is human herpesvirus-8 transmitted by transfusion? Transfus Med Rev 2010; 24:1-14. Review.
3. Goedert JJ, Calamusa G, Dazzi C, et al. Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Infect Agent Cancer 2010; 5:23.
4. Ascoli V, Facchinelli L, Valerio L, Zucchetto A, Dal Maso L, Coluzzi M. Distribution of mosquito species in areas with high and low incidence of classic Kaposi's sarcoma and seroprevalence for HHV-8. Med Vet Entomol 2006; 20:198-208.
5. Coluzzi M, Calabrò ML,Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V. Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol 2003; 17:461-4. (Pubitemid 38448907)
6. Coluzzi M, Calabrò ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V. Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites. J Infect Dis 2004; 190:199-200; Author reply 200-1.
7. Ascoli V, Senis G, Zucchetto Z, et al. Distribution of 'promoter' sandflies associated with incidence of classic Kaposi's sarcoma. Med Vet Entemol 2009; 23:217-25.
8. Anderson LA, Lauria C, Romano N, et al. Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev 2008; 17:3435-43.
9. Valassina M, Cusi MG, Valensin PE. Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy. J Clin Microbiol 1996; 34:2500-2. (Pubitemid 26307800)
10. Erratum in: J ClinMicrobiol 1997; 35(5):1293.
11. R Development Core Team. R statistical software package, version 2.2.0, 2005. www.r-project.org. Accessed 4 January 2010.
12. Ascoli V, Manno D, Coluzzi M. Geographic variation in human herpesvirus 8 seroprevalence and possible association with exposure to bites from blood-sucking arthropods. J Infect Dis 2006; 194:401-2; Author reply 402. (Pubitemid 44121418)
13. Cusi MG, Savellini GG, Zanelli G. Toscana virus epidemiology: from Italy to beyond. Open Virol J 2010; 4:22-8.
14. Papa A, Andriotis V, Tzilianos M. Prevalence of Toscana virus antibodies in residents of two Ionian islands, Greece. Travel Med Infect Dis 2010; 8:302-4.
15. Terrosi C, Olivieri R, Bianco C, Cellesi C, Cusi MG. Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile. Clin Vaccine Immunol 2009; 16:1251-2.
16. Valenti RM, Amodio E, Nam JM, et al. Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls. Br J Cancer 2011; 104: 433-6.
17. Amodio E, Goedert JJ, Barozzi P, et al. Differences in Kaposi sarcomaassociated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. Cancer Sci 2011; doi: 10.1111/j.1349-7006.2011.02032.x.